COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat
COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat
复制标题
DOI:
10.1152/ajpregu.00465.2002
复制
发表时间:
2003-02-01
影响因子:
2.8
通讯作者:
Vizzard, MA
中科院分区:
文献类型:
--
作者:
Hu, VY;Malley, S;Vizzard, MA
The purpose of this study was to determine the role of cyclooxygenase-2 (COX-2) and its metabolites in lower urinary tract function after induction of acute (4 h), intermediate (48 h), or chronic (10 day) cyclophosphamide (CYP)-induced cystitis. Bladders were harvested from euthanized female rats for analyses. Conscious cystometry was used to assess the effects of a COX-2-specific inhibitor, 5,5-dimethyl-3-(3-fluorophenyl)-4(4-methylsulfonyl) phenyl2( 5H)-furanone (DFU, 5 mg/kg sc), a disubstituted furanone, in CYP-induced cystitis. COX-2 mRNA was increased in inflamed bladders after acute (12-fold) and chronic (9-fold) treatment. COX-2 protein expression in inflamed bladders paralleled COX-2 mRNA expression. Prostaglandin D-2-methoxime expression in the bladder was significantly (P less than or equal to 0.01) increased in acute (3-fold) and chronic (5.5-fold) cystitis. Prostaglandin E-2 was significantly (P less than or equal to 0.01) increased (2-fold) in the bladder with intermediate (1.7-fold) and chronic (2.6-fold) cystitis. COX-2-immunoreactive cell profiles were distributed throughout the inflamed bladder and coexpressed histamine immunoreactivity. Conscious cystometry in rats treated with CYP + DFU showed increased micturition intervals 4 and 48 h after CYP treatment and decreased intravesical pressures during filling and micturition compared with rats treated with CYP + vehicle. These studies suggest an involvement of urinary bladder COX-2 and its metabolites in altered micturition reflexes with CYP-induced cystitis.